ADMA Biologics (NASDAQ:ADMA) Sees Large Volume Increase on Analyst Upgrade
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) saw an uptick in trading volume on Thursday after Raymond James raised their price target on the stock from $25.00 to $32.00. Raymond James currently has a strong-buy rating on the stock. 4,407,227 shares changed hands during trading, an increase of 19% from the previous session’s volume […]
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) saw an uptick in trading volume on Thursday after Raymond James raised their price target on the stock from $25.00 to $32.00. Raymond James currently has a strong-buy rating on the stock. 4,407,227 shares changed hands during trading, an increase of 19% from the previous session’s volume […]
